Inogen | INGN - Operating Profit


Inogen reported $-7.79M in Operating Profit for its fiscal quarter ending in September of 2024.





Operating Profit Change Date
Abbott USD 2.13B 281M Jun/2026
Accuray USD 4.71M 6.86M Dec/2024
AngioDynamics USD -2.51M 5.41M Sep/2025
Artivion USD 4.79M 6.85M Dec/2025
AtriCure USD 9.66M 9.14M Jun/2026
Baxter International USD 276M 210M Jun/2026
Becton, Dickinson and Co. USD 752M 125M Jun/2026
Boston Scientific USD 1.24B 190M Jun/2026
Cooper Companies USD 222M 253M Jun/2026
Dexcom USD 318.3M 63M Jun/2026
Edwards Lifesciences USD 519.5M 4.8M Jun/2026
Globus Medical USD -45.97M 209.97M Jun/2026
Inogen USD -7.79M 728K Sep/2024
Insulet USD 129.7M 7.7M Jun/2026
Medtronic USD 1.84B 254M Jun/2026
Orthofix International USD 6.12M 1.91M Dec/2025
Philips EUR 610M 308M Jun/2026
ResMed USD 454.34M 51.33M Jun/2026
Steris USD 285.8M 32.9M Jun/2026
Stryker USD 1.79B 687M Jun/2026
Tandem Diabetes Care USD -13.79M 3.64M Jun/2026
Teleflex USD 73.07M 36.04M Jun/2026
X T L Biopharmaceuticals USD -812K 48K Dec/2024
Zimmer Biomet Holdings USD 344.7M 50.4M Jun/2026